Back to longevity
Directory
Glp
88 documents
doc
/
longevity
/
glp
↖
Parent (longevity)
↘
psychology
7
↘
retatrutide
5
↘
semaglutide
53
↘
tirzepatide
11
Mapping the Effectiveness and Risks of Glp1 Receptor Agonists
2025.01.01
certainty: log
·
importance: 5/10
PDF
4.26 MB
Orforglipron an Oral Smallmolecule Glp1 Receptor Agonist for Obesity Treatment
2025.01.01
certainty: log
·
importance: 5/10
PDF
5.53 MB
Glp1 Parkinsons Disease and Neuroprotection
2024.01.01
certainty: log
·
importance: 5/10
PDF
73.54 KB
The Benefits of Glp1 Drugs Beyond Obesity
2024.01.01
certainty: log
·
importance: 5/10
PDF
324.77 KB
Trial of Lixisenatide in Early Parkinsons Disease
2024.01.01
certainty: log
·
importance: 5/10
PDF
179.81 KB
2 (Frias, 2023)
2023.01.01
certainty: log
·
importance: 5/10
PDF
138.04 KB
Medicare Part D Coverage of Antiobesity Medicationschallenges and Uncertainty Ah
2023.01.01
certainty: log
·
importance: 5/10
PDF
108.62 KB
Patents and Regulatory Exclusivities on Glp1 Receptor Agonists
2023.01.01
certainty: log
·
importance: 5/10
PDF
160.27 KB
The Gutbone Axis in Diabetes
2022.01.01
certainty: log
·
importance: 5/10
PDF
386.64 KB
Schneider
2017.01.01
certainty: log
·
importance: 5/10
PDF
3.17 MB
Normalization of Fasting Hyperglycemia by Exogenous Glucagonlike Peptide 1 736 a
1993.01.01
certainty: log
·
importance: 5/10
PDF
234.04 KB
Orskov
1988.01.01
certainty: log
·
importance: 5/10
PDF
247.16 KB